ClinicalTrials.gg
Drug

Ondansetron clinical trials

Also written Zofran, Zofran ODT, EUR-1025 and GR 38032F.

studies test it
232
open now
28
in phase 3
37
first study started
1998

How each study uses Ondansetron is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Ondansetron studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
4 Jan 1991 · ZOFRAN · NDA 020007 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Ondansetron
135
Ondansetron 8mg
17
Ondansetron 4 MG
10
Ondansetron 8 mg
6
Ondansetron (Zofran)
5

Brand

Zofran
64
Zofran ODT
4
Zofran 8 mg
1
Zophren
1

Development codes

EUR-1025
3
GR 38032F
2
GR-C507/75
2

In one entry with another drug

Given together, or one or the other

Dexamethasone and Ondansetron
3
ondansetron, dexamethasone
2

Studies by the year they started

231 studies that test it; most in 2008 (15)

Studies that test Ondansetron, by start year
YearStudies
19981
20002
20013
20025
20036
20045
20056
20065
20078
200815
200914
20108
201111
20129
20138
20149
201511
20168
20179
20189
20198
202012
202114
20228
20237
20247
20259
202614

By phase

A phase 1/2 study counts in both.

Early Phase 1
5
Phase 1
34
Phase 2
51
Phase 3
37
Phase 4
65
No phase
50

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 36 · Other 196

Tanta University (7) · Assiut University (6) · University of Virginia (5) · University of British Columbia (4) · Stanford University (4) · Merck Sharp & Dohme LLC (4) · GlaxoSmithKline (4) · Par Pharmaceutical, Inc. (4)

Often tested with

Tested in the same studies.

Dexamethasone (33) · Aprepitant (13) · Palonosetron (10) · Metoclopramide (10) · Granisetron (8) · Droperidol (8) · Acetaminophen (5) · Fosaprepitant (4)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 2 phase 3 studies under way

Ondansetron is the comparator. A study of two new drugs counts under both.

  • 1Fosaprepitant · Montefiore Medical Center · next primary completion Mar 2027
Reaching primary completion within a year · 10, 4 in phase 3

Studies that test Ondansetron, phase 3 first.

Studies

Open first, then newest update. How each study uses Ondansetron is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 232

See all 232 studies that test Ondansetron →

Given beside what is tested · 76 — Ondansetron is usual care or a partner of the new treatment

Showing 20 of 76.

As the comparator · 52 — what is tested is compared with Ondansetron

Showing 20 of 52.

Codes

What other systems call Ondansetron · ClinicalTrials.gg INT008573

  • MeSH (NLM) D017294OndansetronConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 4AF302ESOSONDANSETRONConfirmed FDA, NLM, Wikidata
  • RxNorm 26225Confirmed FDA, Wikidata
  • Wikidata Q410011ondansetronConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C1119OndansetronOne source FDA
  • DrugBank DB00904One source Wikidata

Also registered as ondansetron hydrochloride (UNII NMH84OZK2B · RxNorm 203148).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.